Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2005 2
2006 6
2007 4
2008 4
2009 6
2011 5
2012 9
2013 6
2014 5
2015 5
2016 3
2017 8
2018 10
2019 10
2020 9
2021 20
2022 18
2023 15
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

130 results

Results by year

Filters applied: . Clear all
Page 1
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
Das Pradhan A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Ginsberg HN, Goudev A, Ishibashi S, Joseph J, Kodama T, Koenig W, Leiter LA, Lorenzatti AJ, Mankovsky B, Marx N, Nordestgaard BG, Páll D, Ray KK, Santos RD, Soran H, Susekov A, Tendera M, Yokote K, Paynter NP, Buring JE, Libby P, Ridker PM; PROMINENT Investigators. Das Pradhan A, et al. N Engl J Med. 2022 Nov 24;387(21):1923-1934. doi: 10.1056/NEJMoa2210645. Epub 2022 Nov 5. N Engl J Med. 2022. PMID: 36342113 Clinical Trial.
Diagnosis and Management of Sitosterolemia 2021.
Tada H, Nomura A, Ogura M, Ikewaki K, Ishigaki Y, Inagaki K, Tsukamoto K, Dobashi K, Nakamura K, Hori M, Matsuki K, Yamashita S, Yokoyama S, Kawashiri MA, Harada-Shiba M. Tada H, et al. Among authors: ishigaki y. J Atheroscler Thromb. 2021 Aug 1;28(8):791-801. doi: 10.5551/jat.RV17052. Epub 2021 Apr 28. J Atheroscler Thromb. 2021. PMID: 33907061 Free PMC article. Review.
Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial.
Ueki K, Sasako T, Okazaki Y, Kato M, Okahata S, Katsuyama H, Haraguchi M, Morita A, Ohashi K, Hara K, Morise A, Izumi K, Ishizuka N, Ohashi Y, Noda M, Kadowaki T; J-DOIT3 Study Group. Ueki K, et al. Lancet Diabetes Endocrinol. 2017 Dec;5(12):951-964. doi: 10.1016/S2213-8587(17)30327-3. Epub 2017 Oct 24. Lancet Diabetes Endocrinol. 2017. PMID: 29079252 Clinical Trial.
Liver Transplantation for Homozygous Familial Hypercholesterolemia.
Ishigaki Y, Kawagishi N, Hasegawa Y, Sawada S, Katagiri H, Satomi S, Oikawa S. Ishigaki Y, et al. J Atheroscler Thromb. 2019 Feb 1;26(2):121-127. doi: 10.5551/jat.RV17029. Epub 2018 Dec 15. J Atheroscler Thromb. 2019. PMID: 30555131 Free PMC article. Review.
Current Diagnosis and Management of Tangier Disease.
Koseki M, Yamashita S, Ogura M, Ishigaki Y, Ono K, Tsukamoto K, Hori M, Matsuki K, Yokoyama S, Harada-Shiba M. Koseki M, et al. Among authors: ishigaki y. J Atheroscler Thromb. 2021 Aug 1;28(8):802-810. doi: 10.5551/jat.RV17053. Epub 2021 May 14. J Atheroscler Thromb. 2021. PMID: 33994407 Free PMC article. Review.
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022.
Okamura T, Tsukamoto K, Arai H, Fujioka Y, Ishigaki Y, Koba S, Ohmura H, Shoji T, Yokote K, Yoshida H, Yoshida M, Deguchi J, Dobashi K, Fujiyoshi A, Hamaguchi H, Hara M, Harada-Shiba M, Hirata T, Iida M, Ikeda Y, Ishibashi S, Kanda H, Kihara S, Kitagawa K, Kodama S, Koseki M, Maezawa Y, Masuda D, Miida T, Miyamoto Y, Nishimura R, Node K, Noguchi M, Ohishi M, Saito I, Sawada S, Sone H, Takemoto M, Wakatsuki A, Yanai H. Okamura T, et al. Among authors: ishigaki y. J Atheroscler Thromb. 2023 Dec 19. doi: 10.5551/jat.GL2022. Online ahead of print. J Atheroscler Thromb. 2023. PMID: 38123343 Free article. No abstract available.
Identification of serum metabolome signatures associated with retinal and renal complications of type 2 diabetes.
Tomofuji Y, Suzuki K, Kishikawa T, Shojima N, Hosoe J, Inagaki K, Matsubayashi S, Ishihara H, Watada H, Ishigaki Y; BioBank Japan Project; Inohara H, Murakami Y, Matsuda K, Okada Y, Yamauchi T, Kadowaki T. Tomofuji Y, et al. Among authors: ishigaki y. Commun Med (Lond). 2023 Jan 9;3(1):5. doi: 10.1038/s43856-022-00231-3. Commun Med (Lond). 2023. PMID: 36624208 Free PMC article.
Clinical Characteristics of Homozygous Familial Hypercholesterolemia in Japan: A Survey Using a National Database.
Takeji Y, Tada H, Ogura M, Nohara A, Kawashiri MA, Yamashita S, Harada-Shiba M; Committee on Primary Dyslipidemia under the Research Program on Rare and Intractable Disease of the Ministry of Health, Labor, and Welfare of Japan. Takeji Y, et al. JACC Asia. 2023 Sep 19;3(6):881-891. doi: 10.1016/j.jacasi.2023.07.011. eCollection 2023 Dec. JACC Asia. 2023. PMID: 38155796 Free PMC article.
130 results